Welcome to BioIT Alliance Community Server Sign in
HOME | SEARCH | MEMBER DIRECTORY | CALENDAR | VISITOR FAQ
Company Information

    Ocimum Biosolutions is a global life sciences R&D enabling company with three focus areas, BioIT, BioMolecules, and BioResearch. Ocimum delivers end to end genomic products and services out of three strategic locations worldwide, Gaithersburg MD, Indianapolis IN (United States), IJsselstien (The Netherlands), Hyderabad (India).

    The BioIT Division consists of reference databases like The BioExpress® and The ToxExpress® System, Enterprise software solutions like Genesis, web based solutions like ASCENTA® and SCIANTIS® . It also includes three 21 CFR Part 11 & GLP compliant, Lab Information Management Systems (LIMS) products - Biotracker™, Pharmatracker™ and Toxchek™ and a suite of bioinformatics products, Genchek™ (sequence analysis), OptGene™ (gene design), Genowiz™ (microarray data analysis) and iRNAchek™ (iRNA template design). The division also offers specialized data analysis for different kinds of "omics" data and other custom software services.

    The BioResearch Division provides GLP compliant gene expression data generation services. The division provides valuable expertise and services experience in toxicogenomics, biomarkers clinical genomics and consumer genomics area. more...

    The BioMolecules Division produces microarrays and oligonucleotides.

This Member

Syndication

Ocimum

Gene Logic Renews Agreement with Agilent Technologies as Certified Service Provider

GAITHERSBURG, MD and SANTA CLARA, Calif., July 14, 2008 —Gene Logic (An Ocimum Biosolutions Company) and Agilent Technologies today announced that Gene Logic has been reappointed as a Certified Microarray Service Provider for Agilent gene expression microarrays.

The Certified Service Provider (CSP) program comprises a select list of strategic organizations that pass a rigorous assessment to use Agilent’s microarray platform. The program combines the provider’s focused expertise with the complete Agilent microarray workflow to create specialized services or complete genomic research solutions.

“In our continued pursuit of providing customers with the best-suited solution for their research needs, we have found Agilent as a great platform to solve many research questions,” said Anu Acharya, CEO, Gene Logic. “As we continue to expand our services in becoming a preferred global genomics service provider, this partnership will add a lot of value to our partner R&D programs.”

“There is true synergy between the breadth of Gene Logic’s services, and Agilent’s ability to quickly print high-quality custom microarrays,” said Yvonne Linney, Agilent Vice President and General Manager, Genomics. “We’ve enjoyed a long relationship with Gene Logic, and look forward to helping them assist customers to identify and validate new solutions.”

Gene Logic offers one of the largest portfolios of integrated genomic solutions with a vision to become the No. 1 genomics outsourcing company by providing quality solutions spanning across the genomics space and partnering with global organizations in the pursuit for improved and affordable healthcare. Pharmaceutical, biotechnology and diagnostic companies, as well as government and academic institutions worldwide utilize Gene Logic’s comprehensive genomic databases and service resources to enable better understanding of underlying mechanisms of diseases, discovery and prioritization of gene targets and biomarkers. In addition to Agilent, Gene Logic provides microarray, RT-PCR, gene expression and genotyping services on multiple platforms.

About Agilent Technologies:

Agilent Technologies is the world’s premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. Agilent has two primary business segments: Bio-Analytical Measurement and Electronic Measurement. The company has 19,000 employees and serves customers in more than 110 countries. Agilent had revenue of $5.4B in fiscal year 2007.

About Gene Logic (An Ocimum Biosolutions Company):

Gene Logic, headquartered in Gaithersburg, Md., has developed proprietary genomics databases and services to enable customers worldwide to discover and prioritize drug targets, identify biomarkers, predict toxicity, understand mechanisms of toxicity, and obtain insights into the efficacy of specific compounds. As a service, we offer high throughput genomics data generation using validated protocols under GLP compliance on a variety of platforms for clinical trials. Gene Logic is a preferred outsourcing partner for providing integrated biorepository and genomic services for several global pharmaceutical companies. Its global infrastructure, standardized procedures, capacity, expertise and highly skilled staff support drug development programs from pre-clinical target development and toxicogenomic assessment to clinical biomarker identification and patient stratification. In creating one of the most comprehensive commercial gene expression databases – BioExpress® and ToxExpress®, Gene Logic has developed expertise and capabilities that are unparalleled in the genomic services industry. Gene Logic provides multiple GLP-compliant platforms for gene expression and SNP genotyping data generation, full biorepository and genomic services. Besides providing the physical infrastructure for storing thousands of biological samples, Gene Logic provides services to assist sample accrual, IRB approvals, CRO training, sample collection, clinical data capture and management.

The BioIT division provides e-lab information management solutions for life sciences, niche bioinformatics services and products for genomic research such as gene expression analysis, advanced statistical analysis, gene function analysis and genome annotation. The BioMolecules division provides essential molecular biology commodities like DNA oligonucleotides and flexible custom (and catalog) microarrays. All labs and software facilities strategically located in India are ISO 9001:2000 certified.

Visit
www.genelogic.com, www.ocimumbio.com or call toll-free – 1/800/GENELOGIC.

Investor Contact:

Anuradha Acharya
CEO, Gene Logic
Phone: +1 240 364 7502
Email:
ceo@ocimumbio.com

Customer & Media Contacts:

Ashwin Sivakumar
Director – Marketing Alliances and Outreach, Gene Logic
Phone: +91 40-66627200
Email:
pr@ocimumbio.com

Eric Endicott, Agilent Technologies
Phone: +1 408 553 2005
Email:
eric_endicott@agilent.com

NOTE TO EDITORS: Press releases, photography and other information can be accessed on the Agilent Life Sciences and Chemical Analysis newsroom at www.agilent.com/about/newsroom/lsca.

Further technology, corporate citizenship and executive news is available on the Agilent news site at www.agilent.com/go/news.

Published Monday, July 14, 2008 7:24 PM by Ocimum
Filed Under:
Anonymous comments are disabled

About Ocimum

Ocimum Biosolutions is a global life sciences R&D enabling company with three focus areas, BioIT, BioMolecules, and BioResearch. Ocimum delivers end to end genomic products and services out of three strategic locations worldwide, Gaithersburg MD, Indianapolis IN (United States), IJsselstien (The Netherlands), Hyderabad (India).

The BioIT Division consists of reference databases like The BioExpress® and The ToxExpress® System, Enterprise software solutions like Genesis, web based solutions like ASCENTA® and SCIANTIS® . It also includes three 21 CFR Part 11 & GLP compliant, Lab Information Management Systems (LIMS) products - Biotracker™, Pharmatracker™ and Toxchek™ and a suite of bioinformatics products, Genchek™ (sequence analysis), OptGene™ (gene design), Genowiz™ (microarray data analysis) and iRNAchek™ (iRNA template design). The division also offers specialized data analysis for different kinds of "omics" data and other custom software services.

The BioResearch Division provides GLP compliant gene expression data generation services. The division provides valuable expertise and services experience in toxicogenomics, biomarkers clinical genomics and consumer genomics area. more...

The BioMolecules Division produces microarrays and oligonucleotides.